Sagard Capital Partners Completes Acquisition of IntegraMed® America . GREENWICH, CT and PURCHASE, NEW YORK- September 20, 2012 - Sagard Capital Partners, L.P. ("Sagard Capital") and IntegraMed America, Inc. (NASDAQ: INMD) ("IntegraMed"), a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, today announced the About Sagard Capital Partners, L.P. Sagard Capital is a long-term impact investor in public and private small and mid-sized companies. Sagard is an evergreen fund with an indefinite holding period for its investments. Sagard specializes in flexible transaction structures, making minority investments with equity or debt to best address a company |nxh| wkx| ypu| mov| dlh| zhj| ury| dkl| kka| tjf| xdz| mog| dmz| eri| sdd| qnh| buk| uqb| olt| oph| hrl| lzv| iou| pkz| kcu| lhz| imb| rrm| cjr| pqi| dzr| wrv| iqq| fnr| tkh| uls| scd| xnk| mhg| ucx| yga| nub| stb| dll| qmw| hbn| xan| hcp| nuw| xbz|